Again, given the opposite roles of PRMT5 in the tumorigenesis and progression at least in gastric cancer, PRMT5 may regulate different downstream effectors to inhibit or activate Wnt/β-catenin signaling in different context. This evidence concerns the gene PRMT5 and gastric cancer.